{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01883544: Phase 1 Interventional Completed Healthy Subjects
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01647828: Phase 1/Phase 2 Interventional Completed Stage IV Pancreatic Cancer
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03057795: Phase 2 Interventional Active, not recruiting Classic Hodgkin Lymphoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02287896: Phase 2 Interventional Completed Rh Disease
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04374032: Phase 2/Phase 3 Interventional Completed COVID-19 Infection
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01794663: Phase 2 Interventional Completed Delayed Graft Function
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00354926: Phase 1 Interventional Completed Non-Hodgkin's Lymphoma
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04176133: Phase 2 Interventional Completed Healthy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01446159: Phase 2 Interventional Completed Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01015911: Phase 1 Interventional Completed Carcinoma, Renal Cell
(2009)
Source URL:
Class:
PROTEIN
